Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study. - Wikidata - wikimedia - TriplyDB

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

http://www.wikidata.org/entity/Q34186787

about

Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513."One week on-one week off": efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center.Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.The future of high-grade glioma: Where we are and where are we going.Dose-dense temozolomide: is it still promising?Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma.Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme.The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Treating recurrent glioblastoma: an update.The efficacy and safety of various dose-dense regimens of temozolomide for recurrent high-grade glioma: a systematic review with meta-analysis.Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence.Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.Are we done with dose-intense temozolomide in recurrent glioblastoma?Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm.Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy.

P2860

Q27310843-A9BCEEF5-3B2A-4299-828F-F0C0F903BB27 Q33405170-69C40907-46C4-499D-9A74-88EBE213FBF7 Q34426355-52780A06-4A8E-4B5B-8A1D-7B23DB2BC323 Q34886836-6BAF0CCE-3DCC-4121-A16B-2278292141BB Q35114090-83E4788A-C626-4295-BE17-6701B9820487 Q35943654-0F5A1511-09C4-4745-A2E2-2E7255B94412 Q36396360-2F0B8F9E-9404-4EAC-99C8-ADF8350399FF Q36730160-2D3ADDA7-3DD9-4253-8707-48106155FEF8 Q38205133-2DA24DFF-4E9A-4839-80B1-E04A3C82279D Q38376610-E3D6A4BE-B433-4161-949F-21DED1EDF818 Q38579564-311EF4FF-EB1E-40D7-B401-62ED6B313E90 Q38765893-C98850DA-BE8D-414C-A1E4-0B3D31E3D189 Q39417407-DDA620EF-2FFA-410A-86C0-511706A1E933 Q39524840-7AEA5A32-7540-4A39-BC27-6432780B168E Q42804587-58AEAC26-B584-4A95-B148-3CBD7EC53444 Q48706919-47A50DDC-539E-4720-A0EB-90D3AB96CB6C Q48774829-69EB4CB7-15DE-4CFC-B4BC-599349715A3B

P2860

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

http://www.wikidata.org/entity/Q34186787

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@ast

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@en

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@nl

type

label

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@ast

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@en

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@nl

prefLabel

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@ast

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@en

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

@nl

P1433

Q34186787-04BC308B-74B7-423F-9FAC-C10BE50542EC

P1476

Q34186787-9958B037-8342-491C-8967-29E185369D96

P2093

Q34186787-1DAFD87E-322E-43A5-AF27-E3595DCFEC5E

Q34186787-26854C2A-3801-424C-BAD7-9A1404BED657

Q34186787-2E432852-E3E3-47E7-8B11-CA55732A602D

Q34186787-465DAC98-7CDA-41DC-844A-174F5411AD66

Q34186787-6F99F95D-8FCE-4085-BAE6-41BE2CB9E074

Q34186787-A6C990BE-71BF-4A7D-9555-0AC1F4B23220

Q34186787-A9E728B6-F25B-443D-A26A-DC82677CA1F1

P2860

Q34186787-0049FB75-37B4-4700-BC39-C71E17A2D96F

Q34186787-08EEDADC-6F72-453F-82AC-C29E74359D1C

Q34186787-22FB76D3-5FFF-4A78-9117-7CD9B2BDD9DF

Q34186787-32A3D9CF-F6E2-4910-9787-81799EC235EB

Q34186787-404C2173-0895-496B-8FEC-60F76102AC7E

Q34186787-49E5937A-B59B-46D9-B62B-9B5FC9D960F6

Q34186787-4E1400B9-2B04-4ACE-B9CF-C12B7C7EDB87

Q34186787-4F806E09-0C7E-4BB5-B14A-6F4A14854511

Q34186787-668A8B57-CC0D-482B-8F7B-B857748905A6

Q34186787-6BC04397-F690-4CE4-8967-6B65E6406DD9

P2888

Q34186787-6A5FAF08-2488-4122-BF6B-78C3E1997AC8

P304

Q34186787-E45D4109-6FFB-4AAA-9670-F484D934EE35

P31

Q34186787-7C9569DD-6AD7-4B0E-9B0D-8BE0CCF6A443

P356

Q34186787-963B4451-75FE-4519-9C8E-91FB8671D53D

P433

Q34186787-E50E1815-A8FF-45F9-AFB2-A7EBFA2771AD

P478

Q34186787-CB7D3FA1-6964-493D-B011-657F58E78E75

P50

Q34186787-F4C6B29A-8B1C-4DD1-ACE5-69D415717732

P577

Q34186787-78C3BE6F-AB93-4CC6-B6DC-D885EE48EAC7

P5875

Q34186787-0E6DD76E-2C8B-48BD-973C-467F5DA17B69

P6179

Q34186787-269EB519-79BF-4E25-8794-99154A0183AD

P698

Q34186787-3D8541A4-57B2-4DF8-BB85-161D1E2EAE99

P932

Q34186787-C710AB65-83F7-4E98-98A1-E1B55333B7D1

P356

S11060-012-0832-5

P1433

Journal of Neuro-Oncology

P1476

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study

@en

P2093

Carin C D van der Rijt

http://www.w3.org/2001/XMLSchema#string

Irene van Heuvel

http://www.w3.org/2001/XMLSchema#string

Jacoline E Bromberg

http://www.w3.org/2001/XMLSchema#string

Johan M Kros

http://www.w3.org/2001/XMLSchema#string

Joyce M W Segers-van Rijn

http://www.w3.org/2001/XMLSchema#string

Peter A E Sillevis Smitt

http://www.w3.org/2001/XMLSchema#string

Walter Taal

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Ca

P2888

s11060-012-0832-5

P304

195-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-012-0832-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Martin J van den Bent

P577

2012-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221682916

http://www.w3.org/2001/XMLSchema#string

P6179

1029000586

http://www.w3.org/2001/XMLSchema#string

P698

22396071

http://www.w3.org/2001/XMLSchema#string

P932

3337418

http://www.w3.org/2001/XMLSchema#string